FC
HALO icon

FORA Capital’s Halozyme HALO Stock Holding History

FORA Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,832
Closed -$1.23M – 530
2025
Q3 		$1.23M Buy
+16,832
New +$1.12M 0.22% 129
2025
Q2 		– Sell
-27,160
Closed -$1.73M – 585
2025
Q1 		$1.73M Buy
+27,160
New +$1.58M 0.18% 174
2023
Q1 		– Sell
-12,648
Closed -$720K – 592
2022
Q4 		$720K Buy
12,648
+1,654
+15% +$84.7K 0.12% 214
2022
Q3 		$435K Buy
+10,994
New +$486K 0.08% 268
2022
Q2 		– Sell
-6,402
Closed -$257K – 531
2022
Q1 		$257K Buy
+6,402
New +$228K 0.05% 426
2020
Q1 		– Sell
-17,919
Closed -$318K – 1153
2019
Q4 		$318K Buy
+17,919
New +$310K 0.03% 506

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FORA Capital's HALO Position: Q4 2025 in Review

FORA Capital sold out of Halozyme (HALO) in Q4 2025, closing a stake of 16,832 shares — an estimated $1.23M sold.

FORA Capital first reported a position in HALO in Q4 2019 and held it in 6 quarters. The position peaked at $1.73M in Q1 2025. 617 funds tracked by Wall St. Rank hold HALO as of Q4 2025.

  • FORA Capital reported no remaining Halozyme position as of Q4 2025 after selling out during the quarter.
  • FORA Capital sold 16,832 Halozyme shares in Q4 2025, an estimated $1.23M.
  • FORA Capital first reported a position in Halozyme in Q4 2019 and held it in 6 quarters.
  • FORA Capital's Halozyme position peaked at $1.73M in Q1 2025.
  • 617 funds tracked by Wall St. Rank held Halozyme as of Q4 2025.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.